- Home
- OOMA vs VOR Comparison
OOMA vs VOR Comparison
Compare OOMA & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OOMA
- VOR
- Stock Information
- Founded
- OOMA 2003
- VOR 2015
- Country
- OOMA United States
- VOR United States
- Employees
- OOMA N/A
- VOR N/A
- Industry
- OOMA EDP Services
- VOR Biotechnology: Pharmaceutical Preparations
- Sector
- OOMA Technology
- VOR Health Care
- Exchange
- OOMA Nasdaq
- VOR Nasdaq
- Market Cap
- OOMA 310.3M
- VOR 261.0M
- IPO Year
- OOMA 2015
- VOR 2021
- Fundamental
- Price
- OOMA $11.20
- VOR $30.22
- Analyst Decision
- OOMA Strong Buy
- VOR Buy
- Analyst Count
- OOMA 5
- VOR 6
- Target Price
- OOMA $17.63
- VOR $85.33
- AVG Volume (30 Days)
- OOMA 123.5K
- VOR 512.3K
- Earning Date
- OOMA 12-03-2025
- VOR 11-06-2025
- Dividend Yield
- OOMA N/A
- VOR N/A
- EPS Growth
- OOMA N/A
- VOR N/A
- EPS
- OOMA N/A
- VOR N/A
- Revenue
- OOMA $261,617,000.00
- VOR N/A
- Revenue This Year
- OOMA $6.45
- VOR N/A
- Revenue Next Year
- OOMA $5.70
- VOR N/A
- P/E Ratio
- OOMA N/A
- VOR N/A
- Revenue Growth
- OOMA 5.42
- VOR N/A
- 52 Week Low
- OOMA $10.94
- VOR $2.62
- 52 Week High
- OOMA $17.00
- VOR $65.80
- Technical
- Relative Strength Index (RSI)
- OOMA 35.17
- VOR 54.65
- Support Level
- OOMA $10.96
- VOR $29.20
- Resistance Level
- OOMA $11.63
- VOR $33.50
- Average True Range (ATR)
- OOMA 0.33
- VOR 3.90
- MACD
- OOMA -0.09
- VOR -1.87
- Stochastic Oscillator
- OOMA 14.59
- VOR 5.95
About OOMA Ooma Inc.
Ooma Inc is a communications services company. It is a smart software-as-a-service (SaaS) and unified communications platform that deliver voice and collaboration features including messaging, intelligent virtual attendants and video conferencing, and residential phone service provides PureVoice high-definition voice quality, advanced functionality and integration with mobile devices. Its services rely upon the following main elements: multi-tenant cloud service, on-premise devices, desktop and mobile applications, and calling platforms. It generates revenues from the sale of subscriptions and other services.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.